HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gaenzer, H. Articles by Weiss, G.u. Search for Related Content PubMed PubMed Citation Articles by Gaenzer, H. Articles by Weiss, G.u.

CLINICAL STUDY

Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis

^* Department of Internal Medicine, University Hospital, Innsbruck, Austria

Manuscript received March 7, 2002; revised manuscript received August 27, 2002, accepted September 6, 2002.

^* Reprint requests and correspondence: Dr. Günter Weiss, Department of Internal Medicine, University Hospital, Anichstrasse 35, A-6020 Innsbruck, Austria.
guenter.weiss{at}uibk.ac.at

OBJECTIVES: We studied associations between iron status and early functional and structural vascular abnormalities in patients with hereditary hemochromatosis (HH).

BACKGROUND: Iron may be involved in atherogenesis, and patients bearing a genetic mutation associated with HH are possibly at risk of developing coronary heart disease.

METHODS: We studied the vascular properties of 41 HH patients who had homozygosity for the C282Y mutation, along with 51 age-matched control subjects, by determination of endothelium-dependent dilation (EDD) of the brachial artery and intima-media thickness (IMT) of the carotid artery.

RESULTS: Male HH patients who were not receiving phlebotomy therapy showed a reduced EDD and increased IMT compared with controls and HH patients receiving therapy. In female HH patients, irrespective of treatment status, vascular parameters were not different from those of controls, and none of these patients had severe iron overload. In HH patients, increased iron load was significantly associated with reduced EDD and increased IMT. Moreover, we found a positive correlation between body iron stores and indicators of oxidative stress. When previously untreated male HH patients were re-investigated after intensive phlebotomy therapy, a significant improvement in EDD was observed (2.6 ± 1.3% before vs. 5.5 ± 2.1% after treatment, p = 0.0015).

CONCLUSIONS: Impaired endothelial function and increased IMT are associated with iron overload, with subsequent induction of oxidative stress, and are not linked to a genetic disability in HH patients. Consequent iron-depletion therapy normalizes endothelial function and may thus reduce the increased risk of cardiovascular events. Female patients may be at a reduced risk, presumably due to continuous iron loss by menstruation.

Abbreviations and Acronyms   CHD   coronary heart disease   EDD   endothelium-dependent dilation   EID   endothelium-independent dilation   HFE   hemochromatosis gene   HH   hereditary hemochromatosis   IMT   intima-media thickness   MI   myocardial infarction   NO   nitric oxide   ROS   reactive oxygen species   TBARS   thiobarbituric acid–reactive substances

This article has been cited by other articles:

				I. Lenga, C. Lok, R. Marticorena, J. Hunter, N. Dacouris, and M. Goldstein Role of Oral Iron in the Management of Long-Term Hemodialysis Patients Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 688 - 693. [Abstract] [Full Text] [PDF]

				L. M Yunker, J. S Parboosingh, H. E Conradson, P. Faris, P. J Bridge, J. Buithieu, L. M Title, F. Charbonneau, S. Verma, E. M Lonn, et al. The effect of iron status on vascular health Vascular Medicine, May 1, 2006; 11(2): 85 - 91. [Abstract] [PDF]

				D. E. Ferrara and W. R. Taylor Iron Chelation and Vascular Function: In Search of the Mechanisms Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2235 - 2237. [Full Text] [PDF]

				J. L. Sullivan Stored Iron and Vascular Reactivity Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1532 - 1535. [Full Text] [PDF]

				B. Wolff, H. Volzke, J. Ludemann, D. Robinson, D. Vogelgesang, A. Staudt, C. Kessler, J. B. Dahm, U. John, and S. B. Felix Association Between High Serum Ferritin Levels and Carotid Atherosclerosis in the Study of Health in Pomerania (SHIP) Stroke, February 1, 2004; 35(2): 453 - 457. [Abstract] [Full Text] [PDF]

				G. Sengoelge, J. Kletzmayr, I. Ferrara, A. Perschl, W. H. Horl, and G. Sunder-Plassmann Impairment of Transendothelial Leukocyte Migration by Iron Complexes J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2639 - 2644. [Abstract] [Full Text] [PDF]

				S. M. Day, D. Duquaine, L. V. Mundada, R. G. Menon, B. V. Khan, S. Rajagopalan, and W. P. Fay Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis Circulation, May 27, 2003; 107(20): 2601 - 2606. [Abstract] [Full Text] [PDF]

				G. Weiss and H. Gaenzer Reply J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1849 - 1850. [Full Text] [PDF]

				J. Auer, R. Berent, T. Weber, and B. Eber Coronary atherosclerosis and body iron stores J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1848 - 1849. [Full Text] [PDF]